Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | ICICI Pru |
| AUM | ₹1,534 Cr | ₹3,212 Cr |
| NAV | ₹38.9215 | ₹28.1600 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 7.6 years |
| Expense ratio | 1.1% | 1.3% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 41.40 |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| 1 month | — | +10.43% |
| 3 months | — | +1.15% |
| 6 months | — | +9.70% |
| YTD | — | +2.07% |
| 1 year | — | +0.50% |
| 3 years (CAGR) | — | +10.60% |
| 5 years (CAGR) | — | +12.56% |
| 10 years (CAGR) | — | — |
| Since launch | — | +14.57% |
Risk
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| Volatility | — | 16.1% |
| Downside volatility | — | 11.3% |
| Sharpe | — | 0.26 |
| Sortino | — | 0.36 |
| Calmar | — | 0.50 |
| Return / risk | — | 0.66 |
| Deepest fall | — | −31.34% |
| Days to recover | — | 253 |
| Below its high | — | −5.22% |
Against benchmark
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| Alpha | — | −1.83% |
| Beta | — | 0.90 |
| R² | — | 96.5% |
| Up capture | — | 87.2% |
| Down capture | — | 92.2% |
| Tracking error | — | 3.5% |
| Information ratio | — | −0.72 |
| Treynor | — | 0.03 |
Consistency
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| Best 1-year | — | +61.74% |
| Middle 1-year | — | +14.43% |
| Worst 1-year | — | −14.30% |
| 1-year periods with a loss | — | 15.3% |
| Middle 3-year | — | +19.08% |
| Positive months | — | 58.3% |
| Best day | — | +4.16% |
| Worst day | — | −3.15% |
| Worst 5% day | — | −1.33% |
| Positive days | — | 53.8% |
| NAVs a year | — | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| 5-year XIRR | — | +11.45% |
| 5-year value | — | ₹8,04,610 |
| 3-year XIRR | — | +6.07% |
| 1-year XIRR | — | +11.40% |
Holdings overlap i
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| Tata India Pharma & Healthcare Fund Direct · filing Oct 2026 | — | 3% |
| ICICI Prudential Bharat Consumption Fund Direct · filing Oct 2026 | 3% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata India Pharma & Healthcare Fund and ICICI Prudential Bharat Consumption Fund
Overlap
3.0%
smaller weight of each shared stock, added up
Stocks in common
6
of 39 and 55
Weight in common
12% · 3%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | Counts toward overlap |
|---|---|---|---|
| Rainbow Childrens Medicare Limited | 4.02% | 0.99% | 0.99% |
| Nestle India Limited | 1.09% | 0.62% | 0.62% |
| Manipal Health Enterprises Limited | 0.57% | 0.86% | 0.57% |
| Sanofi Consumer Healthcare India Limited | 1.99% | 0.40% | 0.40% |
| Dr Agarwal's Health Care Ltd | 1.31% | 0.25% | 0.25% |
| FDC Limited | 2.69% | 0.14% | 0.14% |
| 6 stocks | 11.7% | 3.3% | 3.0% |
Only in Tata India Pharma & Healthcare Fund (33)
| Sun Pharmaceutical Industries Limited | 7.89% |
| Abbott India Limited | 5.66% |
| Divi's Laboratories Limited | 5.41% |
| Healthcare Global Enterprises Limited | 5.25% |
| Dr. Reddy's Laboratories Limited | 5.14% |
| Torrent Pharmaceuticals Limited | 4.73% |
| Apollo Hospitals Enterprise Limited | 4.55% |
| Max Healthcare Institute Limited | 4.28% |
| Sai Life Sciences Limited | 3.22% |
| Syngene International Limited | 3.17% |
| Procter & Gamble Health Limited | 3.15% |
| Lupin Limited | 3.13% |
| Cipla Limited | 3.08% |
| Anthem Biosciences Limited | 2.99% |
| Natco Pharma Limited | 2.86% |
| Bayer Cropscience Limited | 2.68% |
| Acutaas Chemicals Limited | 2.40% |
| Pfizer Limited | 2.40% |
| Aster DM Quality Care Limited | 2.33% |
| Biocon Limited | 2.23% |
| Navin Fluorine International Limited | 2.15% |
| Ajanta Pharma Limited | 1.59% |
| Alkem Laboratories Limited | 1.40% |
| Gillette India Limited | 1.25% |
| Sumitomo Chemical India Limited | 1.01% |
and 8 smaller holdings (4.1% of the fund).
Only in ICICI Prudential Bharat Consumption Fund (49)
| Hindustan Unilever Limited | 9.46% |
| Bharti Airtel Limited | 9.35% |
| Mahindra & Mahindra Limited | 8.06% |
| Eternal Limited | 4.47% |
| Trent Limited | 4.22% |
| InterGlobe Aviation Limited | 4.13% |
| Maruti Suzuki India Limited | 3.61% |
| Avenue Supermarts Limited | 3.48% |
| ITC Limited | 2.65% |
| TVS Motor Company Limited | 2.60% |
| Titan Company Limited | 2.58% |
| Britannia Industries Limited | 2.49% |
| Jubilant Foodworks Limited | 2.41% |
| Hyundai Motor India Ltd | 2.34% |
| Havells India Limited | 2.08% |
| The Indian Hotels Company Limited | 1.97% |
| International Gemological Institute Limited | 1.64% |
| V-Guard Industries Limited | 1.64% |
| Pidilite Industries Limited | 1.47% |
| Godrej Consumer Products Limited | 1.47% |
| Vedant Fashions Limited | 1.35% |
| Milky Mist Dairy Food Limited | 1.33% |
| Eureka Forbes Ltd. | 1.28% |
| United Breweries Limited | 1.26% |
| Vijaya Diagnostic Centre Limited | 1.07% |
and 24 smaller holdings (12.6% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata India Pharma & Healthcare Fund | ICICI Prudential Bharat Consumption Fund | |
|---|---|---|
| Large companies | 26.8% | 64.3% |
| Mid companies | 30.4% | 10.1% |
| Small companies | 40.2% | 17.6% |
| Top 10 holdings | 50.1% | 52.0% |
| Largest sector | Pharmaceuticals & Biotechnology 64% | Automobiles 17% |